H. B. Fuller Company (NYSE:FUL – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine analysts that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, three have given a buy recommendation and two have given a strong buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $66.20.
Several analysts have recently commented on FUL shares. Weiss Ratings reissued a “hold (c)” rating on shares of H. B. Fuller in a research note on Monday, December 29th. Seaport Res Ptn upgraded H. B. Fuller from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. Citigroup upgraded H. B. Fuller from a “neutral” rating to a “buy” rating and raised their price objective for the company from $62.00 to $70.00 in a research note on Wednesday, October 22nd. UBS Group began coverage on shares of H. B. Fuller in a report on Friday, November 21st. They set a “neutral” rating and a $60.00 price objective on the stock. Finally, Wall Street Zen lowered shares of H. B. Fuller from a “buy” rating to a “hold” rating in a research note on Monday, November 24th.
Get Our Latest Research Report on H. B. Fuller
Insider Transactions at H. B. Fuller
Institutional Investors Weigh In On H. B. Fuller
Large investors have recently made changes to their positions in the business. Cooke & Bieler LP grew its position in H. B. Fuller by 94.9% during the third quarter. Cooke & Bieler LP now owns 1,481,030 shares of the specialty chemicals company’s stock valued at $87,795,000 after buying an additional 721,100 shares during the period. Norges Bank purchased a new position in H. B. Fuller in the second quarter valued at about $40,584,000. UBS Group AG grew its position in shares of H. B. Fuller by 200.8% during the 3rd quarter. UBS Group AG now owns 820,871 shares of the specialty chemicals company’s stock valued at $48,661,000 after acquiring an additional 548,017 shares during the period. Cramer Rosenthal Mcglynn LLC increased its stake in shares of H. B. Fuller by 287.2% during the 3rd quarter. Cramer Rosenthal Mcglynn LLC now owns 371,650 shares of the specialty chemicals company’s stock worth $22,031,000 after purchasing an additional 275,654 shares during the last quarter. Finally, Kennedy Capital Management LLC raised its holdings in shares of H. B. Fuller by 131.2% in the 3rd quarter. Kennedy Capital Management LLC now owns 439,444 shares of the specialty chemicals company’s stock worth $26,050,000 after purchasing an additional 249,350 shares during the period. 95.93% of the stock is owned by hedge funds and other institutional investors.
H. B. Fuller Stock Performance
FUL opened at $60.41 on Friday. H. B. Fuller has a 1-year low of $47.56 and a 1-year high of $65.36. The company has a market cap of $3.27 billion, a price-to-earnings ratio of 32.65, a PEG ratio of 0.98 and a beta of 1.10. The company’s fifty day moving average price is $58.66 and its two-hundred day moving average price is $59.36. The company has a current ratio of 1.93, a quick ratio of 1.18 and a debt-to-equity ratio of 1.06.
H. B. Fuller (NYSE:FUL – Get Free Report) last posted its earnings results on Wednesday, April 13th. The specialty chemicals company reported $0.66 EPS for the quarter. H. B. Fuller had a net margin of 3.28% and a return on equity of 11.49%. The company had revenue of $725.90 million during the quarter. H. B. Fuller has set its FY 2022 guidance at $4.100-$4.350 EPS. On average, analysts expect that H. B. Fuller will post 4.07 EPS for the current fiscal year.
H. B. Fuller Company Profile
H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.
Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.
Further Reading
- Five stocks we like better than H. B. Fuller
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- 3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax
- First Time Since 2007: All Warnings Active
Receive News & Ratings for H. B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
